Neuroimmunology Reports最新文献

筛选
英文 中文
Pediatric Multiple Sclerosis: Unveiling the Trajectory of a Toddler-Onset Case 小儿多发性硬化症:揭开幼儿发病病例的轨迹
Neuroimmunology Reports Pub Date : 2024-07-15 DOI: 10.1016/j.nerep.2024.100222
Rufaidah Rushdi , Nevin Shalaby
{"title":"Pediatric Multiple Sclerosis: Unveiling the Trajectory of a Toddler-Onset Case","authors":"Rufaidah Rushdi ,&nbsp;Nevin Shalaby","doi":"10.1016/j.nerep.2024.100222","DOIUrl":"10.1016/j.nerep.2024.100222","url":null,"abstract":"<div><p>Pediatric multiple sclerosis (MS) is predominantly a relapsing-remitting demyelinating disorder. Toddler-onset MS (12–36 months) is rarely studied despite the likelihood of early-life adversity influencing its incidence. In this case, we present a 9-year-6-month-old girl who first exhibited symptoms at 30 months. Her disease course reflects the challenging mission of reaching a definitive MS diagnosis. Noteworthy observations include a complex perinatal history, initially normal diagnostic workup, and complete recovery after each relapse. It is crucial to recognize the hidden dynamics of MS, namely smoldering MS and the related progression independent of relapse activity, to commence a high-efficacy early treatment modality and establish a comprehensive multidisciplinary management strategy.</p></div>","PeriodicalId":100950,"journal":{"name":"Neuroimmunology Reports","volume":"6 ","pages":"Article 100222"},"PeriodicalIF":0.0,"publicationDate":"2024-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667257X24000238/pdfft?md5=c53ddea9b608eb80571a67a5888cbe36&pid=1-s2.0-S2667257X24000238-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141710339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
FLAIR-hyperintense lesions in anti-MOG-associated encephalitis with seizures (FLAMES) presenting with psychosis and refractory seizures 抗 MOG 相关脑炎伴癫痫发作(FLAMES)中的 FLAIR 高密度病变,表现为精神病和难治性癫痫发作
Neuroimmunology Reports Pub Date : 2024-07-09 DOI: 10.1016/j.nerep.2024.100221
Samantha Anne Gutierrez , Alex Vu , Napo Kasirye-Mbugua , Jodie Burton
{"title":"FLAIR-hyperintense lesions in anti-MOG-associated encephalitis with seizures (FLAMES) presenting with psychosis and refractory seizures","authors":"Samantha Anne Gutierrez ,&nbsp;Alex Vu ,&nbsp;Napo Kasirye-Mbugua ,&nbsp;Jodie Burton","doi":"10.1016/j.nerep.2024.100221","DOIUrl":"10.1016/j.nerep.2024.100221","url":null,"abstract":"<div><p>Myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD) is an idiopathic inflammatory demyelinating disease of the central nervous system commonly associated with optic neuritis, transverse myelitis, acute disseminated encephalomyelitis and cortical encephalitis. A somewhat rare and less recognized syndrome in MOGAD has been identified, and is characterized by cortical encephalitis and seizures with cortical FLAIR-hyperintense lesions on the MRI aptly termed FLAMES (<strong>F</strong>LAIR-hyperintense <strong>L</strong>esions in <strong>A</strong>nti-<strong>M</strong>OG-associated <strong>E</strong>ncephalitis with <strong>S</strong>eizures). We report a previously healthy middle-aged man who presented with focal seizures and status epilepticus refractory to initial interventions. He later developed headache, mood and behavioral changes and ultimately tested positive for anti-MOG antibody in the serum using a fixed cell-based assay. When his MRI was re-assessed in retrospect, it was determined to be in keeping with FLAMES.</p></div>","PeriodicalId":100950,"journal":{"name":"Neuroimmunology Reports","volume":"6 ","pages":"Article 100221"},"PeriodicalIF":0.0,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667257X24000226/pdfft?md5=6860536818566cd5bfe9f7aa2d79514c&pid=1-s2.0-S2667257X24000226-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141629999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neuromyelitis Optica Spectrum Disorders (NMOSD) and structural renal diseases: A literature review 神经脊髓炎视网膜频谱疾病(NMOSD)与结构性肾病:文献综述
Neuroimmunology Reports Pub Date : 2024-06-30 DOI: 10.1016/j.nerep.2024.100220
Zohreh Abna , Seyed Amirhossein Fazeli , Ziba Khanmoradi , Mohammad Ali Sahraian
{"title":"Neuromyelitis Optica Spectrum Disorders (NMOSD) and structural renal diseases: A literature review","authors":"Zohreh Abna ,&nbsp;Seyed Amirhossein Fazeli ,&nbsp;Ziba Khanmoradi ,&nbsp;Mohammad Ali Sahraian","doi":"10.1016/j.nerep.2024.100220","DOIUrl":"https://doi.org/10.1016/j.nerep.2024.100220","url":null,"abstract":"<div><p>Neuromyelitis Optica Spectrum Disorders (NMOSD) is an immune-mediated disease of the central nervous system that often leads to severe attacks of optic nerves and spinal cord. The discovery of Aquaporine 4 (AQP4) antibody as a potential biomarker of NMOSD has changed the global approach to this disease. There have been associations between NMOSD and systemic autoimmune diseases, both organ specific and non-organ specific. Here, we aimed to review the literature on co-incidence or possible association of kidney diseases with NMOSD.</p></div><div><h3>Methods</h3><p>we included All English relevant publications (reviews, original articles, case reports, case series and abstracts) from 1998 to 2023 using PubMed and google scholar database for this review.</p></div><div><h3>Results</h3><p>Nine case reports of co-existing NMOSD with renal disorders were evaluated. The patients were involved from 10–90 years old. The most common association was with nephrotic syndrome and in the context of systemic autoimmune disorders. However a case of NMOSD coincident with renal cell carcinoma without paraneoplastic etiology was reported.</p></div><div><h3>Conclusion</h3><p>Despite the expression of AQP4 in the collecting duct cells of kidney, whether AQP4-IgG, the pathogenic antibody in NMOSD, can damage to the kidney is still unknown.</p><p>Can structural kidney damages lead to AQP4 antigen being exposed to immune system and triggers the cascade of autoimmunity is a question that should be investigated in future studies.</p></div>","PeriodicalId":100950,"journal":{"name":"Neuroimmunology Reports","volume":"6 ","pages":"Article 100220"},"PeriodicalIF":0.0,"publicationDate":"2024-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667257X24000214/pdfft?md5=e281dd2eb65a975e216c4e913f51525a&pid=1-s2.0-S2667257X24000214-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141595000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pancytopenia in neuromyelitis optica spectrum disorder induced by azathioprine-allopurinol interaction 硫唑嘌呤-阿洛嘌呤醇相互作用诱发的神经性脊髓炎视网膜频谱紊乱全血细胞减少症
Neuroimmunology Reports Pub Date : 2024-06-21 DOI: 10.1016/j.nerep.2024.100219
Cesar D. Bautista-Sanchez , Luis E. Martínez-Bravo , Diego A. Hidalgo-Díaz
{"title":"Pancytopenia in neuromyelitis optica spectrum disorder induced by azathioprine-allopurinol interaction","authors":"Cesar D. Bautista-Sanchez ,&nbsp;Luis E. Martínez-Bravo ,&nbsp;Diego A. Hidalgo-Díaz","doi":"10.1016/j.nerep.2024.100219","DOIUrl":"https://doi.org/10.1016/j.nerep.2024.100219","url":null,"abstract":"<div><h3>Background</h3><p>Azathioprine (AZA) remains a widely used treatment for neuromyelitis optica spectrum disorder (NMOSD). It heightens the risk of myelosuppression, a risk further intensified with the addition of allopurinol.</p></div><div><h3>Case presentation</h3><p>To the best of our knowledge, there have been no reported cases of this complication in NMOSD.</p></div><div><h3>Case report</h3><p>We present a 63-year-old female with NMOSD on AZA, who experienced severe myelosuppression upon initiating allopurinol. Following the discontinuation of these drugs, we prescribed granulocyte stimulants, recombinant erythropoietin, and supportive care, which resulted in hematologic improvement.</p></div><div><h3>Conclusions</h3><p>This case highlights a potential myelosuppression risk when combining AZA and allopurinol in NMOSD patients.</p></div>","PeriodicalId":100950,"journal":{"name":"Neuroimmunology Reports","volume":"6 ","pages":"Article 100219"},"PeriodicalIF":0.0,"publicationDate":"2024-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667257X24000202/pdfft?md5=61c35b54f2390ba44144e23ca8c6129b&pid=1-s2.0-S2667257X24000202-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141481654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case report: Neuromyelitis optica spectrum disorder in a patient presented with orbital apex syndrome 病例报告:一名眼眶顶综合征患者的神经脊髓炎视网膜频谱紊乱症
Neuroimmunology Reports Pub Date : 2024-06-11 DOI: 10.1016/j.nerep.2024.100216
Feng Xiang, Xu Zhang, Rongfei Wang, Xiangqing Wang
{"title":"Case report: Neuromyelitis optica spectrum disorder in a patient presented with orbital apex syndrome","authors":"Feng Xiang,&nbsp;Xu Zhang,&nbsp;Rongfei Wang,&nbsp;Xiangqing Wang","doi":"10.1016/j.nerep.2024.100216","DOIUrl":"https://doi.org/10.1016/j.nerep.2024.100216","url":null,"abstract":"<div><h3>Background</h3><p>Orbital apex syndrome as the presentation of neuromyelitis optica spectrum disorder has not been reported in literature.</p></div><div><h3>Case presentation</h3><p>We reported a case in which the patient initially presented with ptosis, diplopia, ophthalmoplegia and visual impairment of the right eye. Clinical examination revealed no light perception in the right eye with the presence of relative afferent pupillary defect and involvement of cranial nerves II, III, V, and VI. Magnetic resonance imaging of the cranial and orbital regions revealed thickening in the intraorbital segment of the right optic nerve with T2-weighted hyperintensity, and Gadolinium-enhancement of the right optic nerve and its myelin sheath. Longitudinally extensive transverse myelitis subsequently developed, with detection of serum anti-aquaporin-4 antibody. Intravenous methylprednisolone was initiated, leading to significant clinical improvement.</p></div><div><h3>Conclusion</h3><p>This case report highlights the diverse manifestations of neuromyelitis optica spectrum disorder, including the orbital apex syndrome.</p></div>","PeriodicalId":100950,"journal":{"name":"Neuroimmunology Reports","volume":"6 ","pages":"Article 100216"},"PeriodicalIF":0.0,"publicationDate":"2024-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667257X24000172/pdfft?md5=7d2932e7bbd9739ff7dbc452293d28ce&pid=1-s2.0-S2667257X24000172-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141481655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe presentation of myelin oligodendrocyte glycoprotein antibody-associated disease: A case report 髓鞘少突胶质细胞糖蛋白抗体相关疾病的严重表现:病例报告
Neuroimmunology Reports Pub Date : 2024-06-10 DOI: 10.1016/j.nerep.2024.100217
Dominique Comeau , Olivia Cull , Yanis Saheb , Remi Leblanc , Ludivine Chamard-Witkowski
{"title":"Severe presentation of myelin oligodendrocyte glycoprotein antibody-associated disease: A case report","authors":"Dominique Comeau ,&nbsp;Olivia Cull ,&nbsp;Yanis Saheb ,&nbsp;Remi Leblanc ,&nbsp;Ludivine Chamard-Witkowski","doi":"10.1016/j.nerep.2024.100217","DOIUrl":"https://doi.org/10.1016/j.nerep.2024.100217","url":null,"abstract":"<div><h3>Background</h3><p>Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is an inflammatory demyelinating disease of the central nervous system. Relapse may be moderate to severe with an Expanded Disability Status Scale (EDSS) above 4.0 in half of patients, albeit most experience good to excellent motor recovery.</p></div><div><h3>Results</h3><p>Herein, we present an atypically severe case of MOGAD with an unusual clinical course. Patient initially presented with diplopia, lower limb motor deficit and hypoesthesia which rapidly deteriorated into quadriplegia. Corticosteroid regimen did not initially translate to significant clinical improvement (EDSS=9.0). At the 1 year follow up, patient had regained some mobility although with marked sequela (EDSS=6.5).</p></div><div><h3>Conclusion</h3><p>Although MOGAD is generally thought to be benign, it could also present with severe episodes.</p></div>","PeriodicalId":100950,"journal":{"name":"Neuroimmunology Reports","volume":"6 ","pages":"Article 100217"},"PeriodicalIF":0.0,"publicationDate":"2024-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667257X24000184/pdfft?md5=06ef7b6b09aee0cdcbb316f6cf60bb56&pid=1-s2.0-S2667257X24000184-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141332976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Susac syndrome with complete triad and concurrent kidney failure treated with plasmapheresis and rituximab: A case report 浆细胞分离术和利妥昔单抗治疗伴有完全性三联征和并发肾衰竭的苏萨克综合征:病例报告
Neuroimmunology Reports Pub Date : 2024-01-01 DOI: 10.1016/j.nerep.2024.100210
Mohammad Amin Sadri , Sarina Loghmani , Zahra Nikoo , Farinaz Tabibian , Vahid Shaygannejad
{"title":"Susac syndrome with complete triad and concurrent kidney failure treated with plasmapheresis and rituximab: A case report","authors":"Mohammad Amin Sadri ,&nbsp;Sarina Loghmani ,&nbsp;Zahra Nikoo ,&nbsp;Farinaz Tabibian ,&nbsp;Vahid Shaygannejad","doi":"10.1016/j.nerep.2024.100210","DOIUrl":"10.1016/j.nerep.2024.100210","url":null,"abstract":"<div><h3>Introduction</h3><p>Susac syndrome (SuS) is a rare autoimmune disease characterized by the clinical triad of brain dysfunction, branch retinal artery occlusion, and hearing loss. Many cases have been reported with irreversible sequelae due to misdiagnosis and late treatment of the disease.</p></div><div><h3>Case</h3><p>In this article, we describe the clinical course and diagnosis of SuS in a young woman with a history of type 1 diabetes mellitus and kidney transplantation who presented with the complete triad. The complex medical history required a tailored treatment approach, including plasmapheresis and rituximab, which significantly improved her condition.</p></div><div><h3>Conclusion</h3><p>This report highlights the diagnostic complexity of SuS and the value of personalized treatment strategies, contributing to the understanding of this rare disorder, and briefly reviews the current knowledge of the disease and discusses the probable pathophysiological relationship between SuS and kidney failure.</p></div>","PeriodicalId":100950,"journal":{"name":"Neuroimmunology Reports","volume":"5 ","pages":"Article 100210"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667257X24000111/pdfft?md5=13d1bb55b1b04759af609450efe4a57e&pid=1-s2.0-S2667257X24000111-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140757340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Progressive multifocal leukoencephalopathy successfully treated with intravenous immunoglobulin 静脉注射免疫球蛋白成功治疗进行性多灶性白质脑病
Neuroimmunology Reports Pub Date : 2024-01-01 DOI: 10.1016/j.nerep.2024.100214
Swansu Batra, Ruchika Tandon, Saurabh Nigam
{"title":"Progressive multifocal leukoencephalopathy successfully treated with intravenous immunoglobulin","authors":"Swansu Batra,&nbsp;Ruchika Tandon,&nbsp;Saurabh Nigam","doi":"10.1016/j.nerep.2024.100214","DOIUrl":"https://doi.org/10.1016/j.nerep.2024.100214","url":null,"abstract":"<div><p>A 52-year-old lady developed apathy, reduced verbal output, decreased visuospatial orientation, cognitive decline, visual impairment and left hemiparesis for 4 months. On MRI head, she displayed T2/FLAIR asymmetric white matter hyperintensities in parietal and occipital lobes and cerebellar peduncle and her CSF PCR was positive for John Cunningham (JC) virus and HIV ELISA and other bacterial, mycobacterial and viral markers were negative, confirming Progressive multifocal leukoencephalopathy (PML). Thereafter, we administered monthly intravenous immunoglobulin (IVIg) and patient's condition and neuroimaging has been improving for past 8 months. Hence, IVIg improving the condition of a potentially fatal disease patient, offers some hope.</p></div>","PeriodicalId":100950,"journal":{"name":"Neuroimmunology Reports","volume":"5 ","pages":"Article 100214"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667257X24000159/pdfft?md5=bf17e38c5cb88fa4347a2b32e7aff696&pid=1-s2.0-S2667257X24000159-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140948779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
On-pump coronary artery bypass graft in a patient with multiple sclerosis: A case report 多发性硬化症患者的冠状动脉旁路移植术:病例报告
Neuroimmunology Reports Pub Date : 2024-01-01 DOI: 10.1016/j.nerep.2024.100200
Osman Fehmi Beyazal , Ferhat Yıldız , Koray Apaydın , Zülfiye Yıldız , Gültekin Saday
{"title":"On-pump coronary artery bypass graft in a patient with multiple sclerosis: A case report","authors":"Osman Fehmi Beyazal ,&nbsp;Ferhat Yıldız ,&nbsp;Koray Apaydın ,&nbsp;Zülfiye Yıldız ,&nbsp;Gültekin Saday","doi":"10.1016/j.nerep.2024.100200","DOIUrl":"https://doi.org/10.1016/j.nerep.2024.100200","url":null,"abstract":"<div><h3>Background</h3><p>Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system characterized by inflammation, demyelination, gliosis, and neuronal loss. The risk of relapse may increase in the perioperative period in surgical interventions, especially in cardiac surgeries performed using cardiopulmonary bypass (CPB) and the use of CPB with MS patients is controversial.</p></div><div><h3>Case presentation</h3><p>In this case report, the management of a patient with MS to reduce the risk of relapse in the perioperative period is described and a case of coronary artery bypass graft (CABG) performed with CPB without any problems is presented.</p></div><div><h3>Conclusions</h3><p>CABG with CPB can be performed successfully in MS patients. Adjusting the operation time and neurological medications, closely monitoring body temperature and electrolytes in the intraoperative and postoperative period, and ensuring hemodynamic stability can reduce the risk of relapse and infection.</p></div>","PeriodicalId":100950,"journal":{"name":"Neuroimmunology Reports","volume":"5 ","pages":"Article 100200"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667257X24000019/pdfft?md5=2da13190a9278f51d62d62d485db16d4&pid=1-s2.0-S2667257X24000019-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139434533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute onset of autoimmune hepatitis after initiation of B cell depletion therapy in multiple sclerosis 多发性硬化症患者接受 B 细胞清除疗法后急性发作自身免疫性肝炎
Neuroimmunology Reports Pub Date : 2024-01-01 DOI: 10.1016/j.nerep.2024.100206
Mara Bahri , Ankur Sheel , Austin Bolker , Wei Chen , Khalid Mumtaz , Cole A. Harrington
{"title":"Acute onset of autoimmune hepatitis after initiation of B cell depletion therapy in multiple sclerosis","authors":"Mara Bahri ,&nbsp;Ankur Sheel ,&nbsp;Austin Bolker ,&nbsp;Wei Chen ,&nbsp;Khalid Mumtaz ,&nbsp;Cole A. Harrington","doi":"10.1016/j.nerep.2024.100206","DOIUrl":"https://doi.org/10.1016/j.nerep.2024.100206","url":null,"abstract":"<div><h3>Background</h3><p>Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease that may coexist in the multiple sclerosis population and remain undiagnosed. AIH has previously been reported following treatment with interferon beta, glatiramer acetate, natalizumab and high dose corticosteroids in people with multiple sclerosis (MS).</p></div><div><h3>Case presentation</h3><p>We present a rare case of autoimmune hepatitis onset after B cell depletion with ocrelizumab in a person with multiple sclerosis (MS).</p></div><div><h3>Case report</h3><p>Two weeks after the second dose of ocrelizumab, patient presented with jaundice and acute liver injury. Liver biopsy revealed pathological features of autoimmune hepatitis with negative workup for viral etiologies. A six month steroid taper and azathioprine resulted in normalization of liver function tests and clinical and radiological stability of multiple sclerosis and AIH at two years of follow-up.</p></div><div><h3>Conclusions</h3><p>Whether B cell depletion with ocrelizumab directly resulted in emergence of AIH is unclear. Regulatory B cells have been proposed to play a protective role in AIH pathogenesis and B cell depletion may provoke the emergence of AIH through loss of regulatory B cells.</p></div>","PeriodicalId":100950,"journal":{"name":"Neuroimmunology Reports","volume":"5 ","pages":"Article 100206"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667257X2400007X/pdfft?md5=f7059dfe0f44995fa5b316e79d181db1&pid=1-s2.0-S2667257X2400007X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140187102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信